TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34042178

Group type: EXPERIMENTAL
Intervention: learn-to-code
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: mathematics
Number of subjects: 174

Group type: COMPARATOR
Intervention: reading
Number of subjects: 174
Study: 32645452

Group type: EXPERIMENTAL
Intervention: Standard online ACP
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Comprehensive online ACP decision aid
Number of subjects: 570

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 570
Study: 35920880

Group type: EXPERIMENTAL
Intervention: Manual therapy
Number of subjects: 80
Study: 32759848

Group type: EXPERIMENTAL
Intervention: EAT: Eating As Treatment intervention
Number of subjects: 390

Group type: COMPARATOR
Intervention: Routine care (control)
Number of subjects: 390
Study: 34543246

Group type: EXPERIMENTAL
Intervention: Sevoflurane-propofol-balanced anesthesia (BA group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol-based total intravenous anesthesia (TIVA group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison of BA vs TIVA
Number of subjects: 60
Study: 32005286

Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (KMC)
Number of subjects: 2188

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 2188
Study: 35075551

Group type: EXPERIMENTAL
Intervention: Single dose intravenous dexamethasone (8 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Periarticular injection of dexamethasone (8 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Divided dose intravenous dexamethasone (two doses of 4 mg separated by 24 hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single intravenous dose group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interval dose group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single low-dose intravenous dexamethasone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Periarticular infiltration of low-dose dexamethasone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single intravenous dexamethasone
Number of subjects: 0
Study: 32536582

Group type: EXPERIMENTAL
Intervention: Saturated fat overfeeding
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Unsaturated fat overfeeding
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Sugar overfeeding
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Overall microbiota community structure
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Baseline levels of Desulfovibrionaceae and Bilophila
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: General microbiota signatures
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Carriage of Bilophila
Number of subjects: 38
Study: 32316995

Group type: EXPERIMENTAL
Intervention: Maintenance Care (MC)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 319
Study: 35021269

Group type: EXPERIMENTAL
Intervention: DS-1211 (3-3000 mg single dose)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: DS-1211 (10-300 mg once daily or 150 mg twice daily for 10 days)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo (10 days)
Number of subjects: 96
Study: 33111530

Group type: EXPERIMENTAL
Intervention: High beverage advertisement receptivity
Number of subjects: 815

Group type: EXPERIMENTAL
Intervention: Low beverage advertisement receptivity
Number of subjects: 815

Group type: EXPERIMENTAL
Intervention: Perceived SSB harm
Number of subjects: 815
Study: 32123978

Group type: EXPERIMENTAL
Intervention: Single-Port TEP (STEP)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Conventional Laparoscopic TEP (CTEP)
Number of subjects: 99
Study: 33333200

Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy (SBRT) - 1 × 18 Gy, 3 × 10 Gy, or 5 × 7 Gy
Number of subjects: 110

Group type: COMPARATOR
Intervention: Conventional Radiation Therapy (cRT) - 1 × 8 Gy, 5 × 4 Gy, or 10 × 3 Gy
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy (SBRT)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Conventional Radiation Therapy (cRT)
Number of subjects: 110
Study: 35175209

Group type: EXPERIMENTAL
Intervention: mHealth intervention (adapted cognitive-behavioral stress management courses and regular physical activity promotion)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 300
Study: 36194412

Group type: EXPERIMENTAL
Intervention: Moxifloxacin eye drops
Number of subjects: 88

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo eye drops
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Topical antibiotics (meta-analysis)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo eye drops (meta-analysis)
Number of subjects: 88
Study: 33509626

Group type: EXPERIMENTAL
Intervention: Nursing faculty's knowledge of fundamental statistical concepts
Number of subjects: 164
Study: 36235871

Group type: EXPERIMENTAL
Intervention: Kiwifruit
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin C Tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32139513

Group type: EXPERIMENTAL
Intervention: TIDieR checklist adherence
Number of subjects: 101

Group type: COMPARATOR
Intervention: Pre-TIDieR publication intervention reporting
Number of subjects: 101

Group type: COMPARATOR
Intervention: Post-TIDieR publication intervention reporting
Number of subjects: 101
Study: 32769914

Group type: EXPERIMENTAL
Intervention: NBP injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: NBP injection placebo
Number of subjects: 0
Study: 33025678

Group type: EXPERIMENTAL
Intervention: Overexpression of LINC01089
Number of subjects: 2

Group type: COMPARATOR
Intervention: Knockdown of LINC01089
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: LINC01089
Number of subjects: 2
Study: 32077737

Group type: EXPERIMENTAL
Intervention: Cooperation After Divorce online intervention platform
Number of subjects: 1856

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1856
Study: 35303068

Group type: EXPERIMENTAL
Intervention: Thoracoscopic oesophagectomy
Number of subjects: 2250

Group type: COMPARATOR
Intervention: Open oesophagectomy
Number of subjects: 2250
Study: 33689966

Group type: EXPERIMENTAL
Intervention: Attribution Questionnaire‐Substance Use Disorder (AQ‐SUD)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Other public stigma scales
Number of subjects: 304

Group type: COMPARATOR
Intervention: Marijuana use disorder vignette
Number of subjects: 304
Study: 35801306

Group type: EXPERIMENTAL
Intervention: Cooperative Learning (CL)
Number of subjects: 1890
Study: 33693968

Group type: EXPERIMENTAL
Intervention: WhyperGAN
Number of subjects: 150

Group type: COMPARATOR
Intervention: H-DenseUnet
Number of subjects: 150
Study: 32558287

Group type: EXPERIMENTAL
Intervention: Remote patient management (RPM)
Number of subjects: 1537

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 1537

Group type: COMPARATOR
Intervention: Usual care (UC) in SR patients
Number of subjects: 1537

Group type: EXPERIMENTAL
Intervention: Remote patient management (RPM) in SR patients
Number of subjects: 1537

Group type: EXPERIMENTAL
Intervention: Remote patient management (RPM) in AF patients
Number of subjects: 1537

Group type: COMPARATOR
Intervention: Usual care (UC) in AF patients
Number of subjects: 1537
Study: 35012535

Group type: EXPERIMENTAL
Intervention: Real-time research ethics approach (RTREA)
Number of subjects: 0
Study: 33290108

Group type: EXPERIMENTAL
Intervention: Dashboard driven infliximab dosing (precision group, PG)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard infliximab dosing (control group, CG)
Number of subjects: 80
Study: 35131978

Group type: EXPERIMENTAL
Intervention: Balance training added to physical therapy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Physical therapy (control group)
Number of subjects: 42
Study: 34226072

Group type: EXPERIMENTAL
Intervention: Point-of-care ultrasound (POCUS)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Radiology-performed ultrasound (RADUS)
Number of subjects: 256
Study: 36440473

Group type: EXPERIMENTAL
Intervention: Intrathecal drug delivery (IDD)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional medical management (CMM)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Cost analysis of pump to CMM
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Intrathecal compounded medications
Number of subjects: 54
Study: 33843980

Group type: EXPERIMENTAL
Intervention: Individualized PEEP (median 18 cm H2O)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Fixed PEEP of 12 cm H2O
Number of subjects: 90

Group type: COMPARATOR
Intervention: Fixed PEEP of 4 to 5 cm H2O
Number of subjects: 90
Study: 35595676

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1787

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1787

Group type: EXPERIMENTAL
Intervention: 2-stent technique in PCI
Number of subjects: 1787
Study: 33346899

Group type: EXPERIMENTAL
Intervention: Surface treatment group (intraoperative spraying and drug-soaked gauze covering the wound combined with local injection into the articular cavity)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Surface treatment group
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (TXA by intravenous drip combined with local injection into the articular cavity)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study: 33607509

Group type: EXPERIMENTAL
Intervention: Integrated cognitive‐behavioral therapy
Number of subjects: 111

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Higher baseline parental monitoring
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Family functioning domains (family roles and affective involvement)
Number of subjects: 111
Study: 33370736

Group type: EXPERIMENTAL
Intervention: Information support method combined with yoga exercise (60 minutes, three times a week for 24 weeks)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 106
Study: 36382708

Group type: EXPERIMENTAL
Intervention: Implant supported fixed dental prosthesis
Number of subjects: 86000

Group type: COMPARATOR
Intervention: Implant supported overdentures
Number of subjects: 86000
Study: 32380889

Group type: EXPERIMENTAL
Intervention: IL‐17A rs2275913 A/A genotype
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: IL‐17A A allele
Number of subjects: 320

Group type: COMPARATOR
Intervention: IL‐17A rs8193036 and rs3748067 SNPs
Number of subjects: 320
Study: 34963211

Group type: EXPERIMENTAL
Intervention: HUPPP plus radiofrequency ablation of tongue base
Number of subjects: 43

Group type: COMPARATOR
Intervention: HUPPP plus traction of tongue base
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Both groups (Ablation and Traction)
Number of subjects: 43
Study: 34917038

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Comparison between groups
Number of subjects: 30
Study: 33043354

Group type: EXPERIMENTAL
Intervention: Glass fiber post
Number of subjects: 150

Group type: COMPARATOR
Intervention: Metal post
Number of subjects: 150
Study: 35999630

Group type: EXPERIMENTAL
Intervention: Danshao Shugan Granules (DSSG)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Silibinin
Number of subjects: 260

Group type: COMPARATOR
Intervention: Rosiglitazone
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: DSSG (in murine model)
Number of subjects: 260
Study: 35102969

Group type: EXPERIMENTAL
Intervention: Strip crowns
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Preformed primary anterior zirconia crowns
Number of subjects: 24
Study: 35177621

Group type: EXPERIMENTAL
Intervention: BCG vaccination followed by Tdap-IPV 3 months later
Number of subjects: 0

Group type: COMPARATOR
Intervention: BCG + Tdap-IPV concurrently
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tdap-IPV followed by BCG 3 months later
Number of subjects: 0
Study: 32150549

Group type: EXPERIMENTAL
Intervention: Weekly healthy lean donor FMT capsules for 6 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo capsules for 6 weeks
Number of subjects: 24
Study: 33938071

Group type: EXPERIMENTAL
Intervention: Active group (HDM immunotherapy)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Active group (HDM immunotherapy) in younger individuals (16-30 years)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo group in younger individuals (16-30 years)
Number of subjects: 182
Study: 32895353

Group type: EXPERIMENTAL
Intervention: Intra articular Hyaluronic acid injections weekly for three weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Atorvastatin 40 milligrams orally daily for 6 months
Number of subjects: 70
Study: 36942062

Group type: EXPERIMENTAL
Intervention: Enoxaparin 60 mg daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Enoxaparin 40 mg daily (Control)
Number of subjects: 60
Study: 36136263

Group type: EXPERIMENTAL
Intervention: Allogeneic umbilical cord blood-derived mesenchymal stem cells (hUCB-MSC) with sodium hyaluronate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Microfracture treatment
Number of subjects: 0
Study: 33323326

Group type: EXPERIMENTAL
Intervention: Intensive individualized nutrition counseling (3 monthly sessions)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (one-time group program)
Number of subjects: 59
Study: 36422170

Group type: EXPERIMENTAL
Intervention: Upper-extremity Biodex balance training program (3 times/week for 8 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Regular weightlifting training routine (control group)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Upper-extremity Biodex balance training program
Number of subjects: 50
Study: 32398433

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC) oxygen
Number of subjects: 271

Group type: COMPARATOR
Intervention: Standard nasal cannula (SNC) oxygen
Number of subjects: 271
Study: 36481752

Group type: EXPERIMENTAL
Intervention: Internet interventions for alcohol use disorders
Number of subjects: 0
Study: 33452173

Group type: EXPERIMENTAL
Intervention: Subcutaneous Abatacept (SC ABA)
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Intravenous Abatacept (IV ABA)
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Concomitant use of methotrexate and glucocorticoids with ABA
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Overall (both SC and IV ABA)
Number of subjects: 343
Study: 32823200

Group type: EXPERIMENTAL
Intervention: 2 mg nicotine gum
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4 mg nicotine gum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heavy smokers
Number of subjects: 0
Study: 35170742

Group type: EXPERIMENTAL
Intervention: Ixekizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34379777

Group type: EXPERIMENTAL
Intervention: Error-Augmentation Training (EAT)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Error-Correction Training (ECT)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Supervised Walking (CTL)
Number of subjects: 54
Study: 35742573

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for cannabis cessation (CBT-CC)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 65
Study: 34022825

Group type: EXPERIMENTAL
Intervention: Neuromuscular exercises
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quadriceps exercises
Number of subjects: 0
Study: 32564557

Group type: EXPERIMENTAL
Intervention: A1762T/G1764A double mutations in HBV DNA
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (mothers without intrauterine transmission)
Number of subjects: 39
Study: 34906745

Group type: EXPERIMENTAL
Intervention: Multifaceted CRC screening intervention including health literacy-directed counseling, simplified materials, motivational interviewing, and motivational reminder messages.
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Enhanced usual care (EUC) arm receiving standard follow-up provided by their clinic or colonoscopy facility.
Number of subjects: 1200
Study: 34453620

Group type: EXPERIMENTAL
Intervention: Ultra-low tidal volume ventilation (3 ml/kg predicted body weight)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Conventional ventilation (6 ml/kg predicted body weight)
Number of subjects: 17
Study: 32997421

Group type: EXPERIMENTAL
Intervention: Group ZZ (tooth brushing)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Group ZZS (tooth brushing and mouth rinsing)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Group ZZSS (tooth brushing, mouth rinsing, and additional miniature toothbrush)
Number of subjects: 33
Study: 35238225

Group type: EXPERIMENTAL
Intervention: D-yogurt (500 mL/day, fortified with 1000 IU of vitamin D)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: D-bread (50 g/day, fortified with 1000 IU of vitamin D)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: D-supplement (1000 IU vitamin D)
Number of subjects: 135

Group type: COMPARATOR
Intervention: P-yogurt (500 mL/day, plain yogurt)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 34289828

Group type: EXPERIMENTAL
Intervention: MiLES intervention (web-based intervention for employers)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 35
Study: 32104687

Group type: EXPERIMENTAL
Intervention: LHTLH (Living High-Training Low)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Normoxic training group (NG)
Number of subjects: 19
Study: 34991940

Group type: EXPERIMENTAL
Intervention: Patellar resurfacing (PR)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Non-patellar resurfacing (non-PR)
Number of subjects: 50
Study: 33475663

Group type: EXPERIMENTAL
Intervention: Polymethoxyflavone purified from Kaempferia parviflora (12 mg per day for 12 weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 32783338

Group type: EXPERIMENTAL
Intervention: Biodentine + ultrasonic activation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Biodentine + hand condensation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: NeoMTA Plus + ultrasonic activation
Number of subjects: 60

Group type: COMPARATOR
Intervention: NeoMTA Plus + hand condensation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ProRoot WMTA + ultrasonic activation
Number of subjects: 60

Group type: COMPARATOR
Intervention: ProRoot WMTA + hand condensation
Number of subjects: 60
Study: 35233508

Group type: EXPERIMENTAL
Intervention: G-chemotherapy
Number of subjects: 195

Group type: COMPARATOR
Intervention: R-chemotherapy
Number of subjects: 195
Study: 32289325

Group type: EXPERIMENTAL
Intervention: Low Energy Density (LED) preload: 1.00 kcal/g; 100 kcal
Number of subjects: 212

Group type: COMPARATOR
Intervention: High Energy Density (HED) preload: 1.60 kcal/g; 160 kcal
Number of subjects: 212
Study: 35957963

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with placebo
Number of subjects: 96

Group type: COMPARATOR
Intervention: Sham acupuncture combined with medication
Number of subjects: 96
Study: 32661644

Group type: EXPERIMENTAL
Intervention: Thrombocytopenia in subgroup B2 (IVH − PHH)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Thrombocytopenia in subgroup B1 (IVH + PHH)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Presence of IVH grades in subgroup B1 (IVH + PHH)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Thrombocytopenia and development of PHH
Number of subjects: 180
Study: 33357465

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 g bolus, followed by continuous infusion of 1 g every 8 h, terminated immediately before aneurysm treatment, or 24 h after start of the medication)
Number of subjects: 955

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 955

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 955
Study: 33051038

Group type: EXPERIMENTAL
Intervention: Unified Protocol (UP)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Single-Disorder Protocol (SDP)
Number of subjects: 179
Study: 35417317

Group type: EXPERIMENTAL
Intervention: WhatsApp Midwife Breastfeeding Support Line counseling and support for two months
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no WhatsApp support)
Number of subjects: 100
Study: 35881513

Group type: EXPERIMENTAL
Intervention: 1-hour fasting group (n = 116)
Number of subjects: 227

Group type: COMPARATOR
Intervention: 2-hour fasting group (n = 111)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 227
Study: 33879015

Group type: EXPERIMENTAL
Intervention: Isotonic intravenous fluid (sodium chloride, 0.9%, and dextrose, 5%)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hypotonic intravenous fluid (sodium chloride, 0.15%, and dextrose, 5%)
Number of subjects: 60
Study: 32788396

Group type: EXPERIMENTAL
Intervention: Baricitinib 2 mg
Number of subjects: 3492

Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg
Number of subjects: 3492

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3492

Group type: EXPERIMENTAL
Intervention: Baricitinib (all doses)
Number of subjects: 3492
Study: 35717008

Group type: EXPERIMENTAL
Intervention: Remote Ischemic Preconditioning (RIPC) applied in 50% (n=60) of patients
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Remote Ischemic Preconditioning (RIPC)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no RIPC)
Number of subjects: 120
Study: 32134754

Group type: EXPERIMENTAL
Intervention: Fixation time of 96 hours with SP142 antibody
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fixation time of 96 hours with SP263 antibody
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fixation times ranging from 12 to 72 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SP142 antibody after 96 hours of fixation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SP263 antibody after 96 hours of fixation
Number of subjects: 0
Study: 33031478

Group type: EXPERIMENTAL
Intervention: Higher adherence to Mediterranean Diet (PREDIMED score >7)
Number of subjects: 309
Study: 34242396

Group type: EXPERIMENTAL
Intervention: Case management plus treatment as usual
Number of subjects: 172

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 172